Form 4: Health Catalyst COO Daniel LeSueur Sells Shares Under 10b5-1 Trading Plan

Health Catalyst's Chief Operating Officer, Daniel LeSueur, sold 5,209 shares of common stock at a price of $7.7034 per share on November 5, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• On November 5, 2024, Daniel LeSueur, the Chief Operating Officer of Health Catalyst, Inc. (HCAT), sold 5,209 shares of the company's common stock.
• The sale was executed at a price of $7.7034 per share.
• This transaction was conducted under a pre-arranged trading plan established on March 7, 2024, in accordance with Rule 10b5-1.
• Following the transaction, LeSueur directly owns 129,690 shares of Health Catalyst common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral. The filing simply reports a stock sale under a pre-arranged trading plan, which doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Insider sales are a common occurrence, and the use of 10b5-1 plans allows insiders to sell shares without being accused of trading on material non-public information. The market typically analyzes these sales in the context of the company's overall performance and future prospects.

Stakeholder Impact

• The stock sale could have a minor negative impact on shareholder sentiment, although the existence of a 10b5-1 plan mitigates this concern.

Key Dates